As of October 2023 Soligenix has a market cap of $5.66 Million. This makes Soligenix the world's 7798th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $5.66 M | -71.03% |
2022 | $19.53 M | -30.98% |
2021 | $28.3 M | -25.9% |
2020 | $38.2 M | 21.12% |
2019 | $31.54 M | 107.41% |
2018 | $15.2 M | -21.52% |
2017 | $19.37 M | 58.43% |
2016 | $12.23 M | -65.38% |
2015 | $35.33 M | 50.71% |
2014 | $23.44 M | -33.63% |
2013 | $35.32 M | 427.17% |
2012 | $6.7 M | 9.48% |
2011 | $6.12 M | -85.1% |
2010 | $41.07 M | -11.5% |
2009 | $46.41 M | 659.85% |
2008 | $6.1 M | -62.09% |
2007 | $16.11 M | -2.39% |
2006 | $16.5 M | 20.79% |
2005 | $13.66 M | -49.21% |
2004 | $26.9 M | -0.4% |
2003 | $27.01 M | 167.1% |
2002 | $10.11 M | -22.93% |
2001 | $13.12 M |
On Oct 3rd, 2023 the market cap of Soligenix was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $373.65 B | 6,601,450.29% | ๐บ๐ธ USA |
![]() Pfizer PFE | $189.74 B | 3,352,175.47% | ๐บ๐ธ USA |
![]() Sanofi SNY | $134.89 B | 2,383,194.99% | ๐ซ๐ท France |
![]() Onconova Therapeutics ONTX | $14.91 M | 163.59% | ๐บ๐ธ USA |
![]() Athersys ATHX | $11.8 M | 108.56% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $10.76 B | 190,075.63% | ๐ฎ๐ฑ Israel |
![]() Cleveland BioLabs
CBLI | $49.06 M | 766.92% | ๐บ๐ธ USA |
![]() Emergent BioSolutions
EBS | $0.15 B | 2,627.62% | ๐บ๐ธ USA |